000			03372dam a22003494a 4500
001			0000068186
003			0001
008			151105s2009 enka b 001 0 eng d
015			_aGBA952543 _2bnb
016	7		_a015266541 _2Uk
020			_a9781848440906 (hbk.)
020			_a1848440901 (hbk.)
035			_a(OCoLC)ocn360205341
040			_aUKM _cUKM _dBWKUK _dBWK _dDLC
042			_alccopycat
050	0	0	_aK3636 _b.A93 2009
082	0	4	_a344.04233 _222
084			_a344.04233 _bABB-G
100	1		_aAbbott, Frederick M.
245	1	0	_aGlobal pharmaceutical policy : _h[Book] : _bensuring medicines for tomorrow's world / _cFrederick M. Abbott, Graham Dukes.
260			_aNorthampton, MA : _aNorthampton, MA : _bEdward Elgar, _cc2009.
300			_ax, 308 pages. : _bill. ; _c25 cm.
504			_aIncludes bibliographical references and index.
505	0		_aThe challenges we face -- Promoting innovation : patents, subsidies, prizes and prices -- Policies on innovation: past, present, and future -- The global regulatory environment : quality, safety, and efficacy -- Medicines for the developing world -- The use of medicines : education, information, and persuasion -- Regulation and the role of the courts -- Specialized policy areas : vaccines, biologicals, and blood products : alternative and traditional medicines : self-medication : counterfeit medicines -- The rich, the poor, and the neglected -- Global and regional policies : the way ahead.
520			_aPharmaceuticals play a central role in health care throughout the world. The pharmaceutical industry is beset with difficulties as increasing research and development expenditure yields fewer new treatments. Public and private budgets strain under the weight of high prices and limited access. The world's poor see little effort to address diseases prevalent in less affluent societies, while the world's wealthy are overusing prescription drugs, risking their health and wasting resources. As the global economic crisis exacerbates pressure on health care budgets, a new presidential administration in Washington, DC has committed to broad health care reform. These circumstances form the backdrop for this extraordinarily timely examination of the global system for the development, production, distribution and use of medicines. The authors are acknowledged experts in the fields of pharmaceutical law and policy, with many years experience advising governments, multilateral organizations and policy-makers on issues involving innovation, access and use of medicines. Supported by a team of independent scientists, doctors and lawyers, they take an insightful look at the issues surrounding global regulation of the pharmaceutical sector, and offer pragmatic suggestions for reform. This book will be of interest to government policy-makers, members of industry, healthcare professionals, teachers, students and lawyers in the fields of public health, intellectual property and international trade.
521			_aAll.
650		0	_aDrugs _xLaw and legislation.
650		0	_aPharmacy _xLaw and legislation.
650		0	_aPharmaceutical policy _xInternational cooperation.
700	1		_aDukes, M. N. G. _q(Maurice Nelson Graham)
852			_p52446 _91100.00 _vNew Public Books _dBooks
999			_c16223 _d16223